Spontaneous reversion of human immunodeficiency virus type 1 neutralization-resistant variant HXB2thr582: in vitro selection against cytopathicity highlights gp120-gp41 interactive regions
- PMID: 7853527
- PMCID: PMC188797
- DOI: 10.1128/JVI.69.3.1860-1867.1995
Spontaneous reversion of human immunodeficiency virus type 1 neutralization-resistant variant HXB2thr582: in vitro selection against cytopathicity highlights gp120-gp41 interactive regions
Abstract
Spontaneous revertants of the immune-selected variant HXB2thr582, which resists neutralization by certain conformationally dependent antibodies specific for the CD4-binding site on gp120 (such as F105), appeared after long-term culture in the absence of immune-selecting serum. Molecular analysis showed some of the viruses in the revertant stock contained a simple back mutation, whereas others retained the Thr-582 codon but contained a substitution of serine for phenylalanine in gp41 at position 673. Neutralization sensitivity to the selecting serum and to F105 of infectious clones containing either the back mutation or the compensatory mutation, HXB2thr582ser673, was confirmed. HXB2thr582-infected cells have a greater propensity for syncytium formation and single cell killing than do either the parental HXB2 or the revertant HXB2thr582ser673. This suggests that the revertant arose by selection in vitro for a less cytopathic virus. Our results link three envelope regions shown to influence virus-cell fusion as well as neutralization by antibody: the CD4-binding region, the leucine zipper domain, and a region hidden to antipeptide antibodies upon envelope oligomerization. Taken together they illustrate the functional importance of the gp120-gp41 interaction and emphasize the impact of the interplay between envelope regions on overall conformation and function and on recognition by neutralizing antibodies.
Similar articles
-
Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes.J Virol. 1998 Sep;72(9):7099-107. doi: 10.1128/JVI.72.9.7099-7107.1998. J Virol. 1998. PMID: 9696803 Free PMC article.
-
An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.Virology. 1993 Sep;196(1):332-7. doi: 10.1006/viro.1993.1484. Virology. 1993. PMID: 8356803
-
Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera.Virology. 1996 Jun 15;220(2):450-60. doi: 10.1006/viro.1996.0332. Virology. 1996. PMID: 8661395
-
Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity.PLoS Pathog. 2013;9(4):e1003218. doi: 10.1371/journal.ppat.1003218. Epub 2013 Apr 4. PLoS Pathog. 2013. PMID: 23592978 Free PMC article.
-
Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter? 1995 Fleming Lecture.J Gen Virol. 1996 Dec;77 ( Pt 12):2905-19. doi: 10.1099/0022-1317-77-12-2905. J Gen Virol. 1996. PMID: 9000081 Review. No abstract available.
Cited by
-
Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits.J Virol. 1999 Apr;73(4):3087-94. doi: 10.1128/JVI.73.4.3087-3094.1999. J Virol. 1999. PMID: 10074159 Free PMC article.
-
Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites.J Virol. 1996 Dec;70(12):8431-7. doi: 10.1128/JVI.70.12.8431-8437.1996. J Virol. 1996. PMID: 8970964 Free PMC article.
-
Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.J Virol. 2017 Feb 14;91(5):e02219-16. doi: 10.1128/JVI.02219-16. Print 2017 Mar 1. J Virol. 2017. PMID: 28003492 Free PMC article.
-
Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.J Exp Med. 1995 Jul 1;182(1):185-96. doi: 10.1084/jem.182.1.185. J Exp Med. 1995. PMID: 7540648 Free PMC article.
-
Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages.J Virol. 2011 Oct;85(20):10699-709. doi: 10.1128/JVI.05510-11. Epub 2011 Aug 10. J Virol. 2011. PMID: 21835796 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials